Welcome to the e-CCO Library!

DOP19: Real-world healthcare resource utilisation among patients with Inflammatory Bowel Disease administered vedolizumab for 6 months
Year: 2020
Source: ECCO'20 Vienna
Authors: Jason Rogers
Created: Tuesday, 23 June 2020, 5:40 PM
DOP20: Can lifestyle and psychosocial factors predict flares of IBD; an exploratory study using telemedicine
Year: 2020
Source: ECCO'20 Vienna
Authors: Greetje Adriaans
Created: Tuesday, 23 June 2020, 5:40 PM
DOP20: Changes in systemic antibody epitope repertoires from preclinical to established Inflammatory Bowel Disease
Year: 2024
Source: ECCO'24 Stockholm
Authors: Bourgonje, Arno R.
Created: Tuesday, 30 April 2024, 5:03 PM
DOP20: The impact of early life antibiotics on the occurrence of paediatric inflammatory bowel disease - a nationwide study from 1995 – 2018
Year: 2023
Source: ECCO’23 Copenhagen
Authors: Mikkel Malham
Created: Friday, 14 July 2023, 2:22 PM
DOP21: Disease activity patterns of paediatric Inflammatory Bowel Disease – A Danish nationwide cohort study 1996-2018
Year: 2023
Source: ECCO’23 Copenhagen
Authors: Mads Damsgaard Wewer
Created: Friday, 14 July 2023, 2:22 PM
DOP21: Histo-endoscopic remission (HEMR) Predicts Future Relapse in Patients with Ulcerative Colitis and is Associated with Lower Colectomy Risk
Year: 2024
Source: ECCO'24 Stockholm
Authors: Lenfant, Matthias
Created: Tuesday, 30 April 2024, 5:03 PM
DOP22: Antibiotic Use as a Risk Factor for Inflammatory Bowel Disease Across the Ages: A Population-Based Cohort Study
Year: 2023
Source: ECCO’23 Copenhagen
Authors: Adam Faye
Created: Friday, 14 July 2023, 2:22 PM
DOP22: Certification of Integral Care IBD Units: Evaluation of a certification program (CUE)
Year: 2020
Source: ECCO'20 Vienna
Authors: Manuel Barreiro-de Acosta
Created: Tuesday, 23 June 2020, 5:40 PM
DOP22: Predictive biomarkers of therapeutic response in Inflammatory Bowel Disease: a step towards personalized medicine.
Year: 2024
Source: ECCO'24 Stockholm
Authors: Baldan-Martin, Montserrat
Created: Tuesday, 30 April 2024, 5:03 PM
DOP23: Decrements in quality of life associated with symptoms of Inflammatory Bowel Disease: results from the UK IBD-BOOST survey
Year: 2023
Source: ECCO’23 Copenhagen
Authors: Chris Roukas
Created: Friday, 14 July 2023, 2:22 PM
DOP23: The role of histology for the prediction of clinical relapse in Crohn’s Disease: A substudy of the STORI cohort
Year: 2024
Source: ECCO'24 Stockholm
Authors: Reenaers, Catherine
Created: Tuesday, 30 April 2024, 5:03 PM
DOP24: Early life exposures and risk for inflammatory bowel disease: a nested case-control study in Quebec, Canada
Year: 2023
Source: ECCO’23 Copenhagen
Authors: Canisius Fantodji
Created: Friday, 14 July 2023, 2:22 PM
DOP25: Antibodies against Neutrophil Extracellular Traps (ANETAs) are associated with more severe disease course in Ulcerative Colitis
Year: 2024
Source: ECCO'24 Stockholm
Authors: Mendieta Escalante, Erick Arturo
Created: Tuesday, 30 April 2024, 5:03 PM
DOP25: Contraceptive method use according to Inflammatory Bowel Disease status among young women in the United States
Year: 2023
Source: ECCO’23 Copenhagen
Authors: Erica Brenner
Created: Friday, 14 July 2023, 2:22 PM
DOP26: Metagenomic and metabolomic profiles in IBD: understanding microbial and metabolic shifts from a large deeply phenotyped cohort
Year: 2024
Source: ECCO'24 Stockholm
Authors: Sokol, Harry
Created: Tuesday, 30 April 2024, 5:03 PM
DOP26: Real-life dosing patterns and concomitant drug use among ustekinumab-treated patients with Crohn’s Disease
Year: 2020
Source: ECCO'20 Vienna
Authors: Clas-Göran Af Björkesten
Created: Tuesday, 23 June 2020, 5:40 PM